Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients
Abstract Patients with coronavirus disease-19 (COVID-19) are at high risk for thrombotic arterial and venous occlusions. However, bleeding complications have also been observed in some patients. Understanding the balance between coagulation and fibrinolysis will help inform optimal approaches to thr...
Guardado en:
Autores principales: | Yu Zuo, Mark Warnock, Alyssa Harbaugh, Srilakshmi Yalavarthi, Kelsey Gockman, Melanie Zuo, Jacqueline A. Madison, Jason S. Knight, Yogendra Kanthi, Daniel A. Lawrence |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/15613acf473e49538de79328cd7add3a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Plasminogen Activator Inhibitor-1 Protects Mice Against Cardiac Fibrosis by Inhibiting Urokinase-type Plasminogen Activator-mediated Plasminogen Activation
por: Kamlesh K. Gupta, et al.
Publicado: (2017) -
PLASMINOGEN ACTIVATOR OF YERSINIA PESTIS
por: V. V. Evseeva, et al.
Publicado: (2015) -
Deep mutational scanning of the plasminogen activator inhibitor-1 functional landscape
por: Zachary M. Huttinger, et al.
Publicado: (2021) -
Recombinant tissue plasminogen activator in the treatment of suprachoroidal hemorrhage
por: Nancy Kunjukunju, et al.
Publicado: (2011) -
Intra-Arterial Tissue Plasminogen Activator for Central Retinal Artery Occlusion
por: Sobol EK, et al.
Publicado: (2021)